Treatment of premenstrual dysphoric disorder (PMDD) with a novel formulation of drospirenone and ethinyl estradiol

Premenstrual dysphoric disorder (PMDD) is a severe form of premenstrual syndrome (PMS). Pharmacologic options studied for treating severe PMS and PMDD may include selective serotonin reuptake inhibitors, anxiolytic agents, gonadotropin-releasing hormone agonists and the diuretic spironolactone. Howe...

Descripción completa

Detalles Bibliográficos
Autores principales: De Berardis, Domenico, Serroni, Nicola, Salerno, Rosa Maria, Ferro, Filippo Maria
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2007
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374943/
https://www.ncbi.nlm.nih.gov/pubmed/18472980

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374943/
https://www.ncbi.nlm.nih.gov/pubmed/18472980

Ejemplares similares